Evidence map›Paper›PMID 23044834›Full record

ReviewAnatomical record (Hoboken, N.J. : 2007)2012

The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.

Cameron L Budenz, Bryan E Pfingst, Yehoash Raphael

Open access · greenAbstract readReview
In one paragraph

Review in Anatomical record (Hoboken, N.J. : 2007), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Nerve Growth Factor and Autoimmune Diseases.Current issues in molecular biology · 2023
    Review
  6. Comparison Between the Effect of Intra-Scalar Methylprednisolone and Sodium Hyaluronate in Impedance and Electrically Evoked Compound Action Potentials in Cochlear Implant Patients.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  7. Cochlear Health and Cochlear-implant Function.Journal of the Association for Research in Otolaryngology : JARO · 2023
    Review
  8. Article
  9. The BDNF/TrkB Neurotrophin System in the Sensory Organs of Zebrafish.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Expression and Localization of BDNF/TrkB System in the Zebrafish Inner Ear.International journal of molecular sciences · 2020
    Article
  14. Article
  15. Article
  16. CaBP1 regulates CaMolecular and cellular neurosciences · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cameron L BudenzKresge Hearing Research Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.
Bryan E Pfingst
Yehoash Raphael
University of Michigan–Ann Arbor · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOLAN, DAVID FRANCIS · 2002 to 2016
$10.3M
Advanced Research Training in OtolaryngologyT32DC005356 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CORFAS, GABRIEL · 2002 to 2021
$3.5M
Cochlear Implants in Reinnervated EarsR01DC010412 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 2010 to 2014
$2.2M
Acoustic and electrical hearing after Atoh1 treatmentR01DC007634 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PFINGST, BRYAN E · 2006 to 2010
$1.6M
NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30-DC05188NIDCD NIH HHS R01 DC007634NIDCD NIH HHS R01-DC007634NIDCD NIH HHS R01 DC010412NIDCD NIH HHS R01-DC010412NIDCD NIH HHS T32 DC005356NIDCD NIH HHS T32-DC005356
6 · The paper itself

Abstract

Severe to profound deafness is most often secondary to a loss of or injury to cochlear mechanosensory cells, and there is often an associated loss of the peripheral auditory neural structures, specifically the spiral ganglion neurons and peripheral auditory fibers. Cochlear implantation is currently our best hearing rehabilitation strategy for severe to profound deafness. These implants work by directly electrically stimulating the remnant auditory neural structures within the deafened cochlea. When administered to the deafened cochlea in animal models, neurotrophins, specifically brain derived neurotrophic factor and neurotrophin-3, have been shown to dramatically improve spiral ganglion neuron survival and stimulate peripheral auditory fiber regrowth. In animal models, neurotrophins administered in combination with cochlear implantation has resulted in significant improvements in the electrophysiological and psychophysical measures of outcome. While further research must be done before these therapies can be applied clinically, neurotrophin therapies for the inner ear show great promise in enhancing CI outcomes and the treatment of hearing loss.

Indexed as

Cochlear ImplantationAnimalsCochleaDeafnessEar, InnerHumansNerve Growth FactorsNerve Growth Factors

Identifiers

PMID23044834
PMCPMC4081524
OpenAlexW2017068359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.